Calumet to Attend Goldman Sachs Leverage Finance Conference
Tweet
Share
E-mailGet Alerts CLMT Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 16.3%
Revenue Growth %: +15.7%
Join SI Premium – FREE
About Calumet
Calumet, Inc. (NASDAQ: CLMT) manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. Calumet is headquartered in
View original content:https://www.prnewswire.com/news-releases/calumet-to-attend-goldman-sachs-leverage-finance-conference-302778173.html
SOURCE Calumet, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- iQIYI AIGC Series "The Ferry Man" Exceeds RMB 8 Million in Revenue-Sharing as Third Instalment Debuts on October 1
- ANCA-associated Vasculitis Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2034 – DelveInsight | Novartis, Amgen, GSK, AstraZeneca, Chemocentryx, Staidson
- Tissue Heart Valves Market to Reach USD 25,307.93 Million by 2034, Driven by Rising Valvular Heart Disease Cases, TAVR Expansion, and Technological Advancements
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
